#6627 on the rich list of 14,644 insiders
Mark Sullivan
Chief Legal Officer at Definium Therapeutics. Based in New York, New York.
$14.5M
in disclosed stock, +$133K (+0.93%) today
Live prices, last trade 3:03 PM ET
- Rank
- 6627th of 14,644
- Companies held
- 1
- Largest holding
- DFTX, 100.0% of total
- Latest SEC filing
- Sep 25, 2026
What the $14.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Definium Therapeutics DFTX Common Shares | Directly | 494,228 | $29.39 | $14.5M | 100.0% | Form 4, Sep 25, 2026 |
Share counts are the amounts Mark Sullivan reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 6624 | Joseph D. Burns Chief Executive Officer, AIRO Group Holdings. Mclean, VA | $14.5M |
| 6625 | Louis C. McMurray Director, Community West Bancshares. Fresno, CA | $14.5M |
| 6626 | Scott Schaeffer Chair Board and CEO, Independence Realty Trust. Philadelphia, PA | $14.5M |
| 6627 | Mark Sullivan Chief Legal Officer, Definium Therapeutics. New York, NY | $14.5M |
| 6628 | Richard E. Perlman Director, Onterris. North Little Rock, AR | $14.5M |
| 6629 | Tyler Jacks Director, Amgen. Waltham, MA | $14.5M |
| 6630 | Ray M. Robinson Director, FTAI Aviation. New York, NY | $14.5M |
Other Definium Therapeutics insiders
All DFTX insiders- Robert Barrow$65.0MChief Executive Officer. #2116 overall
- Daniel Karlin$23.3MChief Medical Officer. #4636 overall
- Brandi Roberts$11.6MChief Financial Officer. #7869 overall
- Matthew T. Wiley$10.6MChief Commercial Officer. #8458 overall
- Schond Greenway$6.2MChief Financial Officer. #12484 overall
- Miri Halperin Wernli$5.9MExecutive President. #12870 overall
Questions
How much stock does Mark Sullivan own?
Mark Sullivan holds $14,525,361 in listed stock based on SEC filings and current prices, mostly Definium Therapeutics (DFTX). That ranks 6627th on the Stock Rich List.
Is this Mark Sullivan's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Mark Sullivan last buy or sell stock?
The most recent open-market trade on file is a sale of 14,051 DFTX shares on Sep 25, 2026 at $36.57.